Redefining and measuring transplant conditioning intensity in current era: a study in acute myeloid leukemia patientsAlexandros Spyridonidis, Mohamad Mohty, Jan J. Cornelissen et al.|Bone Marrow Transplantation|2020Cited by 202
Clinical practice recommendation on hematopoietic stem cell transplantation for acute myeloid leukemia patients with <i>FLT3</i>-internal tandem duplication: a position statement from the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationAli Bazarbachi, Mohamad Mohty, Gesine Bug et al.|Haematologica|2020Cited by 137
Evaluation of Trends and Prognosis Over Time in Patients with AML Relapsing After Allogeneic Hematopoietic Cell Transplant Reveals Improved Survival for Young Patients in Recent YearsAli Bazarbachi, Mohamad Mohty, Christoph Schmid et al.|Clinical Cancer Research|2020Cited by 81
Management of patients with acute leukemia during the COVID-19 outbreak: practical guidelines from the acute leukemia working party of the European Society for Blood and Marrow TransplantationÉolia Brissot, Mohamad Mohty, Myriam Labopin et al.|Bone Marrow Transplantation|2020Cited by 74
Post-transplant cyclophosphamide versus antithymocyte globulin in patients with acute myeloid leukemia in first complete remission undergoing allogeneic stem cell transplantation from 10/10 HLA-matched unrelated donorsÉolia Brissot, Mohamad Mohty, Myriam Labopin et al.|Journal of Hematology & Oncology|2020Cited by 68